Insider Holders & Insider Ownership - Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

List of insiders holdings for Biohaven Pharmaceutical Holding Co Ltd.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Doogan Declan
Director
2022-02-11 21:44:020
1,308,989
1,308,989Form 5
Coric Vlad
Chief Executive Officer
2022-10-03 20:26:32830,891
0
830,891Form 4
Berman Robert
Special Projects & Med Ovrsght
2020-07-10 21:15:52341
790,550
790,891Form 4
PORTAGE BIOTECH INC.
former 10% owner
2018-01-25 16:13:4554,494
0
54,494Form 4/A
AGUIAR ERIC
Director
2020-01-24 18:43:420
26,250
26,250Form 4
Cha Albert
Director
2018-05-03 17:21:2318,000
0
18,000Form 4
Repella Robert
Director
2019-05-23 18:37:1518,000
0
18,000Form 4
Tilton John
Chief Commercial Officer
2022-10-03 20:27:091,614
0
1,614Form 4
Engelhart James
Strategic Advisor
2022-10-03 20:30:300
0
0Form 4
CHILDS JOHN W
Director
2022-10-03 20:29:120
0
0Form 4
Buten Matthew
Chief Financial Officer
2022-10-03 20:28:300
0
0Form 4
Mehta Kishan
Director
2022-10-03 20:27:510
0
0Form 4
Heffernan Michael Thomas
Director
2022-10-03 20:26:270
0
0Form 4
JONES WILLIAM A JR
CCO-Migraine & Common Disease
2022-10-03 20:25:520
0
0Form 4
GREGORY JULIA P
Director
2022-10-03 20:25:530
0
0Form 4
HUGIN ROBERT J
Director
2022-10-03 20:25:100
0
0Form 4
Antonijevic Irina
Director
2022-10-03 20:25:100
0
0Form 4
Clark George C.
VP, Chief Accounting Officer
2022-10-03 20:24:250
0
0Form 4
Stock Elyse
Chief Medical Officer
2022-10-03 20:23:450
0
0Form 4
Bailey Gregory
Director
2022-10-03 20:23:470
0
0Form 4
Conway Charles
Chief Scientific Officer
2022-10-03 20:23:030
0
0Form 4
Gentile Kimberly
SVP, Clinical Operations
2022-10-03 20:20:090
0
0Form 4